Fluimucil – a mucolytic drug with antioxidant properties.
Thins sputum, increases its volume and facilitates its separation.
The action of acetylcysteine is associated with the ability of its sulfhydryl groups to break the intramolecular and intermolecular disulfide bonds of acid mucopolysaccharides of sputum, which leads to the depolarization of mucoproteins and a decrease in the viscosity of sputum.
Preserves activity in the presence of purulent sputum.
It has an antioxidant effect due to the presence of the SH group capable of neutralizing electrophilic oxidative toxins.
It also has an anti-inflammatory effect (due to the suppression of the formation of free radicals and active oxygen-containing substances responsible for the development of inflammation in the lung tissue).
Respiratory diseases associated with the formation of increased viscosity sputum (acute and chronic bronchitis, pneumonia, bronchiectasis, cystic fibrosis, bronchial asthma) to facilitate the discharge of mucus in sinusitis.
Diseases of the respiratory system, accompanied by the formation of sputum with increased viscosity.
Hypersensitivity to acetylcysteine, peptic ulcer of the stomach and duodenum in the acute stage, age up to 18 years (effervescent tablets).
Caution should be given to patients with liver and kidney disease.
Use during pregnancy and lactation
Use during pregnancy and breastfeeding is only possible if the intended benefits to the mother outweigh the potential risk to the fetus or baby.
For patients with bronchial asthma and obstructive bronchitis, fluimucil can only be prescribed if adequate sputum drainage is provided.
Dosage forms for oral administration contain aspartame, therefore, they should not be prescribed to patients with phenylketonuria.
When dissolving the drug, use glassware and avoid contact with metal and rubber surfaces.
When opening the bag with granules, the smell of sulfur is possible, which is the smell of the active substance, and not an indication of the poor quality of the drug.
1 tablet contains acetylcysteine ??600 mg
Dosage and administration of
1 tablet dissolved in 1/3 cup of water and taken 1 time per day.
Duration of treatment should be evaluated individually.
In acute diseases, the duration of treatment is from 5 to 10 days and up to several months in the treatment of chronic diseases (on the recommendation of a doctor).
From the digestive system: rarely – heartburn, nausea, vomiting, diarrhea, stomatitis.
Allergic reactions: rarely – skin rash, itching, urticaria, bronchospasm.
Other: rarely – nosebleeds, tinnitus, collapse, decreased platelet aggregation.
Local reactions: with parenteral administration, a slight burning sensation at the injection site is possible with inhalation administration – a reflex cough, local respiratory tract irritation, stomatitis, rhinitis rarely – bronchospasm (in this case bronchodilators must be prescribed).
In the dark place at a temperature of no higher than 25 ° C.
Form of Treatment
tablets rastvorim e
Zambon S.p.A., Italy